We would love to hear your thoughts about our site and services, please take our survey here.
Shareholder Dealing The Company had hoped to establish and operate a matched bargain service to enable shareholders wishing to buy and sell Sphere Medical shares to find counterparties. We have received advice that because of MiFID II (the Markets in Financial Instruments Directive) it will not be possible for the Company to operate such a service.
Funny auld game is football....:-) Nice one boys!!
Well put JL....well put my good man!!
Completion of fundraising Sphere Medical Holding Limited, an innovative point-of-care monitoring and diagnostic devices company, announces that, further to the announcement on 21 August 2017, the Investment and Cancellation process is complete. Gross proceeds of the Investment were �5.1 million. The Company now has in issue 141,757,872 Ordinary Shares and 179,912,380 Convertible Preferred Shares. Funds managed by Woodford Investment Management Limited own 57.3% of the Company�s issued share capital and The Wales Life Sciences Investment Fund LP owns 18.8% of the Company�s issued share capital.
Change of Chief Executive Officer Sphere Medical Holding Limited, an innovative point-of-care monitoring and diagnostic devices company, announces that, Luci�n van Os, currently Chief Operating Officer, is to take over as Chief Executive Officer from Wolfgang Rencken, who is stepping down from the Board this month. Luci�n joined Sphere in June 2015 as COO. He has more than 12 years� experience in the medical device industry. An engineer by background, Luci�n has significant experience in bringing new technologies and products to the market. Luci�n has previously been CEO of some small and mid-sized medtech companies and has held senior and general management positions at Medtronic and Gambro. After close to 4 years at Sphere Medical and having successfully secured the future of the Company as a privately held entity with a new strategy, Wolfgang is stepping down as CEO to spend more time back in Germany with his family. Wolfgang will remain with Sphere until at least the end of 2017 and has committed to help in any way possible to ensure a well-structured and smooth transition. David Martyr, Chairman, said, �We would like to take this opportunity to thank Wolfgang for his tremendous contributions to our Company, his strategic vision and hard work to transform and guide the Company during his time in office and wish him all the best of success and happiness in his future pursuits. We are confident that Luci�n will be an excellent leader of the Company as it enters this important new phase of development.�
Wolfgang even alluded to it at one of the presentations last year...I know it looks bleak...but who knows...the application could be used in other devices that we are not aware of yet. One thing is for sure...self testing technology is here and it is thanks to devices becoming idiot proof and produced smaller that this is happening. If we manage to get a sensor that can house all the analytes of a real blood gas machine on the Proxima...then who knows where it could end up in... The new data analysis position is to use all the incoming data from the current Proxima devices currently out in the market place and already attached to patients, to utilize the sensor to the maximum....Quite a lot of data is likely coming in now from the training hospitals that have taken delivery so far...Much bigger bank of data been built up now for the product....
The contracts allow for a notice period of time to be served...so we could easily have changes in the months a head... Along side the R&D...is an improved distributors deal in place....for whatever comes out of Proxima. The direct sales thing was a non starter....but we had no choice...I still think and hope that the sensor will have applications going forward for other devices as it is improved...
Salary �40,000 Sphere Medical is a dynamic company based in Cambridge UK, specialising in the development of innovative medical monitoring and diagnostic equipment. The Company�s strategy is focused on developing its flagship product, the Proxima platform for on-patient, near real-time measurement of key blood analytes (gases, electrolytes, metabolites�). Proxima is designed to benefit a wide spectrum of patients, enabling faster decision making and improved clinical outcomes, whilst reducing cost. The Company has established partnerships with renowned research hospitals enabling the on-patient use of the current generation of Proxima (CE-marked device) in the OR and the ICU, and is as a result generating a wealth of invaluable real-world data. In-house testing adds to this volume of data, including that from the next generation Proxima with a clear path towards automated operation and a greatly expanded analyte panel. We are looking for a Senior Data Analysis and Algorithms Engineer, to join the Sensor and Algorithm Development Group. The role is varied, and its scope may be adapted to play to the strengths of the successful applicant, but shall encompass two core areas. Firstly the maintenance and development of the data infrastructure, processing tools and databases to aid R&D. Secondly the development of new algorithms to enhance the performance and capabilities of the current and future versions of Proxima. Working at Sphere Medical represents the opportunity to experience first-hand the complete cycle of medical device development from initial concept generation through to regulatory approval and roll-out. As such the Company provides an environment which tests its employees whilst expanding their skillsets.
Now that was quite satisfying.....:-)
They held 3% of 141 million shares....not now..
Looking forward to this one...not usually an international type person...but this one looks tasty...if the first match in Dublin is anything to go by!!
I did notice that his portfolio has a lot of private companies in it...He does seem to like local bio tech start up companies....and fair play to him for looking long term......As long as we continue to get funding...it does seem to make sense...not to be at the whim of the market, that has no long term views anymore..... Good article JL...thanks for that... Still surprised this board is still open.......very strange but nice...
Dont think Ortho bailed out...I think they just sunk below the 3% mark after the issuing of the CPS the other day.... May still be holding but just didn't add....... My understanding is that just like a placing...if the offer is not taken they are just cancelled, unlike with a rights issue....
I haven't posted on that board...but can do if you are having difficulty on the other site... Just book mark it...not much to say I would imagine..
They have recently started using dissolving micro cameras that can take thousands of images of the internal body before been excreted out after the job is done... So I agree...lots of changes underway out there...
Like wise here JL...Will remain a holder but it might be a handy page to see if there is any sp news as a private company. The web site seems to be under construction of sorts....but they may keep us up to some kind of speed. There are lots of things they no longer have to do as a private company but they may still do all the same..
The SPHR is putting a matched bargain page up shortly... http://www.spheremedical.com/investor-relations/share-holder-information/shareholder-dealing Not up and running yet but worth book marking if you still hold shares here... Also the web site appears to be changing so perhaps they will give some news in time. I have subscribed for news updates...again worth doing if you are still a holder....
I think the FTO BB stayed open for about a week after it went....
I've had response from the CFO Richard Wright re:matched bargaining. It appears that the company website will have a section for matched bargaining in due course. Due course feels like a few months, but lets see - was expecting a spreadsheet to maintain data not an interactive website tool. All good.
JL is still in here......like me self....